In Congress, he is fighting to expand Medicare, protect Social Security, and reduce prescription drug costs.
Jared Moskowitz will work to reduce prescription drug costs.
Occurrences
Evidence
Congressman Jared Moskowitz (D-FL-23) joined colleagues to introduce the Affordable Loans for Students Act, saying the legislation moves forward by capping student loan interest rates at 2% across the board. While this is about student loans rather than prescription drugs, it is the clearest recent official example of Moskowitz pursuing affordability legislation through Congress.
The office announced a federal grant for a local arts project and emphasized helping students and families. This is constituent-service activity, not prescription-drug policy action.
The Clerk’s member page shows Jared Moskowitz serving as Florida’s 23rd District representative in the 119th Congress and lists his committee assignments, confirming active federal office during the current term.
The official office homepage shows recent 2026 updates and ongoing constituent services and press activity, but no specific prescription-drug-cost accomplishment or bill tied to that issue in the lookback window.
The Clerk’s committee page lists Jared Moskowitz as a Democrat on the Oversight and Intelligence Subcommittee in the 119th Congress, confirming continued participation in House committee work during the current term.
This recorded House vote shows Moskowitz participated in floor action in late April 2026, demonstrating active legislative engagement in the lookback window, but the vote shown is not related to prescription-drug costs.
This recent House roll call provides another instance of active participation in chamber business during May 2026, but no prescription-drug-cost-specific measure is evident from the vote page itself.
Assessments
The promise is broad—'will work to reduce prescription drug costs'—and the provided evidence does not show any prescription-drug-specific bill sponsorship, vote, amendment, executive action, public advocacy, or enacted result attributable to Jared Moskowitz. The evidence mostly confirms that he remains active in office and participating in House business, plus one affordability-related student-loan bill that is not about prescription drugs. Because there is no concrete evidence here either of delivery or of a serious attempt on this specific issue, the best judgment from this record is unresolved rather than delivered, partial, or never.